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There is an increasing appreciation of the polymicrobial nature of many bacterial
infections such as those associated with cystic ﬁbrosis (CF) and of the potentially
important role for interspecies interactions in inﬂuencing both bacterial virulence
and response to therapy. Patients with CF are commonly co-infected with Pseu-
domonas aeruginosa and other pathogens including Burkholderia cenocepacia and
Stenotrophomonas maltophilia. These latter bacteria produce signal molecules of
the diffusible signal factor (DSF) family, which are cis-2-unsaturated fatty acids.
We have previously shown by in vitro studies that DSF from S. maltophilia leads to
altered bioﬁlm formation and increased resistance to antibiotics by P. aeruginosa;
these responses of P. aeruginosa require the sensor kinase PA1396. Here we show
that DSF signals are present in sputum taken from patients with CF. Presence
of these DSF signals was correlated with patient colonisation by S. maltophilia
and/or B. cenocepacia. In animal experiments using CF transmembrane conductance
regulator knockout mice, the presence of DSF promoted P. aeruginosa persistence.
Furthermore, antibiotic resistance of P. aeruginosa bioﬁlms grown on human airway
epithelial cells was enhanced in the presence of DSF. Taken together, these data
provide substantial evidence that interspecies DSF-mediated bacterial interactions
occur in the CF lung and may inﬂuence the efﬁcacy of antibiotic treatment,
particularly for chronic infections involving persistence of bacteria.
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Objectives: Progressive lung disease, driven by inﬂammation secondary to chronic
bacterial infection, constitutes the chief burden of CF. We describe a systems biology
investigation of the pathogenesis of Pseudomonas aeruginosa infected CF airways
aiming to identify biomarkers/pathways as potential targets for improved therapy
or for use as prognostic indicators.
Methods: We employed multi-dimensional LC-MS/MS to semi-quantitatively con-
trast the cellular protein proﬁles of sputum from CF and control cohorts. Impor-
tantly, our approach effectively assesses the activity of CF cells directly in their
in vivo environment, so taking into account the interactions between host and the
highly complex CF microbiome.
Results: 119 of the 2309 human proteins detected were common to all samples
(36 CF + 12 control). Of these, 49 were down-regulated and 29 up-regulated
in CF (p< 0.05). Additionally, 21 proteins were detected exclusively in all CF
samples and 17 proteins exclusively in all controls. Analysis for biological relevance
using Ingenuity Pathway Analysis (IPA) software identiﬁed molecular and cellular
functions belonging to the categories of Cell Death; Cellular Movement; Protein
Synthesis, Degradation, Trafﬁcking & Post-Translational Modiﬁcation; Cell-to-Cell
Signalling and Interaction; Free Radical Scavenging; and Cellular Assembly and
Organisation as divergent between the study cohorts.
Conclusions: Comparison of the infected CF cellular proteome with IPA disease
proﬁles showed up-regulation of proteins previously identiﬁed in Respiratory, Im-
munological and Inﬂammatory Diseases, and down-regulation of proteins associated
with Cancer and Neurological Disease.
